Clinical trial
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol…
NCT00249132 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00249132 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia |
| Official title | Risperidone Versus Haloperidol Versus Placebo in the Treatment of Chronic Schizophrenia |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 523 |
| Completion | Jul 1, 1991 |
| First posted | Nov 7, 2005 |
| Last update posted | Feb 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: